A 52-year-old woman with tetralogy of Fallot status post-complete surgical repair with infundibular resection, pulmonary valvotomy, and patch closure of the ventricular septal defect presented with severe pulmonary regurgitation and depressed right ventricular function. During intended percutaneous pulmonary valve implantation (PPVI), multiple stenotic lesions were discovered in her left anterior descending (LAD) coronary artery, and the procedure was aborted. She underwent treatment of these lesions using drug-eluting stents by our adult interventional colleagues and returned to the congenital catheterization laboratory for PPVI 18 months following her initial procedure. Given the potential risk of crush injury to the coronary arterial stents, the distal LAD artery was continuously monitored during the procedure via a pressure wire with the capability of re-expanding the stent if needed.
Introduction
Percutaneous pulmonary valve implantation (PPVI) is an effective method for treating right ventricular outflow tract (RVOT) obstruction and regurgitation in patients with congenital heart disease [1, 2, 3] . A rare but catastrophic complication of PPVI is mechanical coronary artery compression due to implantation of a stent and/or valve within the RVOT [4] . Coronary artery testing is recommended during balloon angioplasty of the RVOT to assess coronary artery compression or distortion. However, the presence of an existing coronary artery stent may render coronary artery testing with balloon angioplasty/compliance testing a higher risk procedure. Here, we report the first use of a pressure wire within a stented left anterior descending (LAD) coronary artery in close proximity to the RVOT during PPVI to assess for coronary artery stent compromise and to maintain access for treatment of compression with redilation of the stent or re-stent if necessary.
Case Presentation
A 52-year-old woman with tetralogy of Fallot presented to our adult congenital cardiology program for evaluation. She underwent complete surgical repair at 8 years of age consisting of infundibular resection, pulmonary valvotomy, and patch closure of a ventricular septal defect. Her residual atrial septal defect was closed with a CardioSEAL™ Occlusion Device (Nitinol Medical Technologies, Ind., Boston, Massachusetts) at 38 years of age. Past medical history was also significant for diabetes mellitus and hypertension. As a result of her surgical palliation, the patient had severe pulmonary valve regurgitation with decreased right ventricular function and was referred for PPVI. Prior to RVOT intervention, multiple stenotic lesions were discovered within her LAD, and the procedure was aborted (Figure 1 ). Over the next few months, the patient underwent percutaneous coronary intervention by our adult interventional colleagues with a total of three drug-eluting stents placed along her proximal, mid, and distal LAD. After surveillance coronary angiography revealed no residual coronary arterial narrowing, the now 54-year-old patient was referred back to the congenital cardiac catheterization laboratory for PPVI.
Following hemodynamic evaluation, three-dimensional rotational angiography was performed for the RVOT with simultaneous selective left coronary angiography to delineate the spatial relationship between the RVOT and left coronary artery (Videos 1 and 2 Figure 2 ). The course of the left main coronary artery was immediately posterior to the RVOT but superior to the intended transcatheter valve landing zone at the level of the native pulmonary valve annulus. The stented LAD was anterior and leftward to the RVOT. Angiography of the RVOT showed a dilated RVOT that narrowed to 16.7 × 20.1 mm at the level of the native pulmonary valve (Video 3, Figure 3 ). We next planned on performing CA Pressure Wire During PPVI balloon sizing of the RVOT with a low-pressure balloon. Given the risk of coronary stent compression with balloon angioplasty, stent implantation, and PPVI within the RVOT, we decided to continuously monitor distal LAD pressure during the intervention. This plan was discussed with our adult interventional colleagues, who were prepared to provide support as needed. A 6-F JL-4 Guiding catheter (Cordis®, Milpitas, California) was used to cannulate the left main coronary artery, and a 0.014" PrimeWire Prestige® PLUS pressure guide wire (Volcano Co., San Diego, California) was positioned in the distal LAD (Video 4, Figure 4 ). The measured pressure from the pressure wire was calibrated with the proximal coronary arterial pressure measured from the guide catheter. A 2.5 × 15 mm Maverick coronary balloon (Boston Scientific Co., Marlborough, Massachusetts) was prepped and ready for use in the case of a crush injury to a coronary artery stent during RVOT intervention.
Sizing of the RVOT was performed using a 25 mm × 4 cm Tyshak II balloon (B. Braun Medical Inc., Bethlehem, Pennsylvania) inflated to 1 atm. Selective left coronary angiography and continuous LAD pressure monitoring was performed during balloon sizing of the RVOT. Both the proximal left coronary No coronary arterial compression was demonstrated by angiography. There was a 19.8-mm waist on the sizing balloon, and pre-stenting of the RVOT was completed with two Palmaz 3110 XL stents (Cordis®, arterial and distal LAD coronary arterial pressures decreased equally and simultaneously during inflation of the sizing balloon and completely recovered to baseline with balloon deflation ( Figure 5 ). Figure 6 ). The pressure wire and JL guide catheter were then removed. Intracardiac echocardiographic evaluation of the Melody TPV revealed trivial central valvar regurgitation and no paravalvar leak (Video 6). The patient tolerated the procedure without complication and was discharged home on Aspirin 325 mg and Clopidogrel 75 mg daily. formation about the relationship of the coronary arteries to the RVOT, it cannot completely predict the final interaction between the patient's anatomy, pre-stents, and TPV. A recent study used three-dimensional rotational angiography to improve our understanding of coronary artery anatomy during PPVI [12] . In our case, both two-dimensional and three-dimensional angiography were used to evaluate the relationship between the stented left coronary artery and the RVOT prior to any intervention. The accepted technique of coronary artery testing during balloon angioplasty of the RVOT is effective if the compression or distortion of the coronary artery is relieved by deflation of the balloon. However, with a stent already present in the at-risk LAD, deflating the balloon may not relieve the coronary artery compression. A stent implanted within the RVOT or coronary artery may prevent reversible coronary arterial compression. Here, we describe the first PPVI in a patient with coronary arterial stents that were
Discussion
Coronary artery compression during PPVI has been reported in multiple case series with outcomes varying from symptomatic acute coronary syndrome to cardiac arrest [5, 6, 7, 8, 9, 10, 11] . Morray and colleagues retrospectively evaluated coronary artery testing in 404 patients referred for PPVI in a multi-institutional study [4] . The risk of coronary artery compression in the study was 4.7% for all patients, with a risk of 71% for patients with abnormal coronary artery anatomy (i.e., left coronary artery arising from the right coronary artery, status post-Ross procedure). Additional risk factors for coronary artery compression included tetralogy of Fallot and transposition of the great arteries. Given this potential catastrophic outcome, coronary arterial testing with a balloon of equal size to the intended pre-stent implantation balloon is recommended and is the standard of care during PPVI. Although coronary artery testing provides good in- were potential masses (e.g., calcification, scar tissue) in addition to the pre-stents that could result in coronary artery compression. Continuous distal LAD pres-sure monitoring provided a constant assessment of coronary perfusion during the intervention and not just during angiographic balloon testing of the RVOT. As expected, pressures in both the proximal left main and distal LAD coronary arteries equally decreased with obstruction of the RVOT during balloon compliance testing, stent implantation, and PPVI, which resulted in a temporary decrease in left ventricular preload. In addition, both pressures recovered equally upon deflation of the balloons. Coronary artery stent compression would have been identified if either of the two following scenarios were present following balloon deflation: (1) a discrepancy between the two pressure waveforms indicating coronary artery stenosis or (2) both pressures not returning to baseline values as a result of acute left ventricular dysfunction.
Had there been evidence of coronary artery compression, the JL guide catheter positioned in the left main coronary artery would have allowed us to advance the prepped coronary balloon over the pressure wire to re-expand the stent. Currently, the estimated number of adults with congenital heart disease in the United States is greater than 1 million [13] . As the congenital heart disease patient population ages, there will be an increasing number of patients with combined acquired cardiovascular disease in addition to their underlying congenital heart disease. With technological advancements in transcatheter therapies, a greater proportion of this patient population will receive percutaneous treatment in the catheterization laboratory. The interventional cardiologist must be mindful of both types of heart disease in the older patient. This procedure was performed in the congenital cardiac catheterization laboratory given the need for biplane imaging during PPVI. Our adult interventional colleagues were prepared to provide any assistance in the event of a coronary intervention. Adult congenital heart disease programs have bridged the gap between pediatric and adult cardiac care and can often assist in the planning of complicated interventional procedures in adult congenital heart disease patients. Close collaboration between congenital and adult interventional cardiology is needed to provide the best care to this patient population.
In conclusion, coronary artery compression is a risk of PPVI and should be routinely evaluated. Continuous coronary arterial pressure monitoring via a pressure wire can facilitate PPVI in high-risk patients with coronary arterial stents. Given the risk of coronary artery stent compression, these high-risk procedures should be performed with support from adult interventional cardiology.
